Evommune EVMN
NYSE EVMN
$8.30 -0.05 (-0.60%)
As of: Sep 30, 2026 · 1:31 PM EDT

Evommune, Inc. (EVMN) EBT (2024 - 2026)

Updated

Evommune's EBT was -$32.24 million in Q2 2026, compared with -$22.59 million a year earlier.

Analysis

Evommune, Inc. (EVMN) EBT (2024 - 2026) Analysis & Trends

On a trailing twelve-month basis, Evommune's EBT was -$94.65 million through Jun 30, 2026; for FY2025, it was -$77.75 million.

  • In earlier years, EBT was -$66.77 million in FY2024.
  • The Q2 2026 figure marks the lowest quarterly EBT in data going back to Q3 2024.
  • Per Business Quant data, EVMN's EBT in the three quarters before Q2 2026 was -$21.67 million (Q1 2026), -$28.27 million (Q4 2025) and -$12.47 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -32.24 Mn
Mar 31, 2026 -21.67 Mn
Dec 31, 2025 -28.27 Mn
Sep 30, 2025 -12.47 Mn
Jun 30, 2025 -22.59 Mn
Mar 31, 2025 -14.42 Mn
Dec 31, 2024 -20.73 Mn
Sep 30, 2024 -15.90 Mn
API Access

Evommune, Inc. EBT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt&ticker=EVMN&period=max&api_key=YOUR_API_KEY